[Transarterial Periarticular Embolization (TAPE) for Treatment of Achillodynia: Initial Results]

Overview

Journal Orthopadie (Heidelb)

Specialty Orthopedics

Date 2024 Dec 5

PMID 39632971

Authors

Marcus Katoh

Henrike Ziegler

Peter Schott

Bettina Touloumtzidis

Ludger Feyen

Clayton Kraft

Patrick Freyhardt

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, transarterial periarticular embolization (TAPE) has received increasing attention in the treatment of chronic joint pain, which can be caused by degenerative changes such as osteoarthritis but also by inflammatory changes in the capsule-ligament apparatus.

Objectives: The aim of this study is to describe the method as well as preliminary results of TAPE in the treatment of therapy-resistant achillodynia.

Material And Methods: TAPE was used in the treatment of seven patients (female: 1, male: 6) with chronic achillodynia. The technical success rate and complication rates were analyzed. Furthermore, the changes in subjective pain were assessed using a visual analogue scale (VAS) and the load-bearing capacity using the Foot and Ankle Disability Index (FADI).

Results: All procedures were performed successfully (technical success rate: 100%); no complications were observed. In the first postoperative week, pain was reduced from an initial average VAS of 8.2 to 4.2. After 12 months, there was a further reduction to 1.4. At the same time, based on the FADI, the Achilles tendon load capacity increased on average from 45.4 initially to 60.1 after 1 week and to 89.9 after 12 months.

Conclusion: Our results suggest that TAPE may be a new, promising procedure in the treatment of therapy-resistant, chronic achillodynia. This technically demanding but minimally invasive procedure, performed only under local anesthesia, can significantly reduce pain and restore the patient's ability to bear weight.

References

Albert H, Sorensen J, Christensen B, Manniche C . Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy. Eur Spine J. 2013; 22(4):697-707. PMC: 3631045. DOI: 10.1007/s00586-013-2675-y. View

Alfredson H, Ohberg L, Forsgren S . Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sports Traumatol Arthrosc. 2003; 11(5):334-8. DOI: 10.1007/s00167-003-0391-6. View

Hirschmuller A, Morath O . [Tendinopathies of the Achilles tendon]. Z Rheumatol. 2021; 80(7):629-640. DOI: 10.1007/s00393-021-01006-2. View

Jarvinen T . Neovascularisation in tendinopathy: from eradication to stabilisation?. Br J Sports Med. 2019; 54(1):1-2. PMC: 6923943. DOI: 10.1136/bjsports-2019-100608. View

Katoh M, Schott P, Freyhardt P, Feyen L, Ziegler H, Kraft C . [Transarterial Periarticular Embolization (TAPE): Indications and Initial Experience in Germany]. Rofo. 2020; 192(11):1046-1052. DOI: 10.1055/a-1212-6149. View

Kaux J, Forthomme B, Le Goff C, Crielaard J, Croisier J . Current opinions on tendinopathy. J Sports Sci Med. 2013; 10(2):238-53. PMC: 3761855. View

Koucheki R, Dowling K, Patel N, Matsuura N, Mafeld S . Characteristics of Imipenem/Cilastatin: Considerations for Musculoskeletal Embolotherapy. J Vasc Interv Radiol. 2021; 32(7):1040-1043.e1. DOI: 10.1016/j.jvir.2021.04.006. View

Martin R, Irrgang J, Burdett R, Conti S, Van Swearingen J . Evidence of validity for the Foot and Ankle Ability Measure (FAAM). Foot Ankle Int. 2005; 26(11):968-83. DOI: 10.1177/107110070502601113. View

Millar N, Murrell G, McInnes I . Inflammatory mechanisms in tendinopathy - towards translation. Nat Rev Rheumatol. 2017; 13(2):110-122. DOI: 10.1038/nrrheum.2016.213. View

10.

Okuno Y, Matsumura N, Oguro S . Transcatheter arterial embolization using imipenem/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management. J Vasc Interv Radiol. 2013; 24(6):787-92. DOI: 10.1016/j.jvir.2013.02.033. View

11.

Ott O, Jeremias C, Gaipl U, Frey B, Schmidt M, Fietkau R . Radiotherapy for benign achillodynia. Long-term results of the Erlangen Dose Optimization Trial. Strahlenther Onkol. 2015; 191(12):979-84. DOI: 10.1007/s00066-015-0893-4. View

12.

Riley G, Curry V, DeGroot J, van El B, Verzijl N, Hazleman B . Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002; 21(2):185-95. DOI: 10.1016/s0945-053x(01)00196-2. View

13.

Saxena A, Hong B, Hofer D . Peritenolysis and Debridement for Main Body (Mid-Portion) Achilles Tendinopathy in Athletic Patients: Results of 107 Procedures. J Foot Ankle Surg. 2017; 56(5):922-928. DOI: 10.1053/j.jfas.2017.04.020. View

14.

Weidermann F, Hirschmuller A, Tamborrini G . [CME Sonography 108: Achilles Tendon Ultrasound: Sonoanatomy and Pathologies]. Praxis (Bern 1994). 2023; 112(4):271-282. DOI: 10.1024/1661-8157/a004032. View